Publicly traded company on the OTC Market, Halberd Corporation (OTCMKTS:HALB) on July 22, 2021 confirmed shipping metallic nanoparticles conjugated to Alzheimer’s Disease antibodies, Tau and Phosphorylated Tau.
The firm has completed conjugation of metallic nanoparticles,GreenBioAZ shipped the materials to Youngstown State University.
Dr. William G. Sturrus, Chair of the Physics, Astronomy, Geology, and Earth Sciences Department and his team will start next steps at the YSU. This involves eradicating conjugated AD building blocks through its unique, proprietary laser eradication process. This is being done after the promising results from starting tests with metal conjugated antibodies against E. coli. Tau and Phosphorylated Tau, linked with Alzheimer’s Disease.
William A. Hartman, Halberd’s Chairman, President & CEO, said that the company is beginning testing on eliminating the first two building blocks related with Alzheimer’s Disease. Hartman added that the company will carry on work on additional targeted proteins as well as cytokines related to AD and PTSD/Chronic Traumatic Encephalopathy.
The CEO also said that the company’s Laser experimentation has advanced quickly than the planned parallel but the experiments harnessing radio frequency have demonstrated the need to procure a stronger RF power unit. The company also awaits parallel experimentation of different and simpler patent-pending Chemical Bonding Process in Pittsburgh, Pennsylvania.
Market Reaction:
As of 12:13, HALB stock soared 84% at $0.0254 with more than 99.79 million shares, compared to its average volume of 4.28 million shares. The stock has moved within a range of $0.0140 – 0.0355 after opening the trade at $0.0140. Over the past 52-week, the stock has been trading within a range of $0.0038 – 0.1090.
 Stock Soars On heavy Volume: How to Trade Now?){kind=link}